Study guide
9.2 Otitis Media, Epistaxis & Vertigo
DHA Healthcare Professional Licensing Assessment - General Practitioner/Doctor Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Chronic Cardiovascular & Endocrine Disorders
1.1 Hypertension Management in Primary Care 1.2 Type 2 Diabetes Mellitus Management 1.3 Dyslipidemia & Thyroid Disorders
2 Chapter 2: Chronic Respiratory, Renal & Musculoskeletal Disorders
2.1 Asthma & COPD Maintenance 2.2 Chronic Kidney Disease 2.3 Chronic Musculoskeletal & Rheumatological Conditions
3 Chapter 3: Acute & Common Medical Problems
3.1 Common Infections in Primary Care 3.2 Anemia & Hematological Disorders 3.3 Acute Neurological Problems 3.4 Common Gastrointestinal Complaints
4 Chapter 4: Emergency Problems & Resuscitation
4.1 Cardiopulmonary Resuscitation & Shock 4.2 Acute Metabolic & Toxicological Emergencies 4.3 Trauma Assessment & Environmental Emergencies
5 Chapter 5: Common Pediatric Problems
5.1 Acute Pediatric Respiratory Infections 5.2 Febrile Seizures & Childhood Dehydration 5.3 Neonatal Jaundice & Pediatric Developmental Milestones
6 Chapter 6: Women's Health & Obstetric Care
6.1 Antenatal Care, Pre-eclampsia & Gestational Diabetes 6.2 Contraception & Menopause 6.3 Common Gynecological Conditions
7 Chapter 7: Common Surgical Problems
7.1 Acute Abdomen 7.2 Hernias, Hemorrhoids & Testicular Torsion 7.3 Abdominal Aortic Aneurysm & Urological Emergencies
8 Chapter 8: Common Psychiatric Problems
8.1 Mood & Anxiety Disorders 8.2 Psychosis, Delirium & Substance Use 8.3 Suicide Risk Assessment & Crisis Intervention
9 Chapter 9: Common Eye & ENT Problems
9.1 Acute Red Eye, Glaucoma & Uveitis 9.2 Otitis Media, Epistaxis & Vertigo 9.3 Common Upper Respiratory ENT Infections
10 Chapter 10: Common Dermatology Problems
10.1 Acne & Psoriasis 10.2 Eczema, Dermatitis & Skin Infections 10.3 Skin Infestations & Cutaneous Malignancies
11 Chapter 11: Family Medicine Concepts & Health Promotion
11.1 Patient-Centered Care & Continuity 11.2 Immunization & Travel Medicine 11.3 Smoking Cessation & Lifestyle Medicine
12 Chapter 12: Screening & Preventive Medicine
12.1 Cancer Screening 12.2 Cardiovascular & Metabolic Risk Screening
13 Chapter 13: Epidemiology, EBM, Ethics & UAE Regulations
13.1 Basic Epidemiology & Outbreak Measures 13.2 Evidence-Based Medicine & Study Designs 13.3 Professionalism, Ethics & UAE Regulations
9.2 Otitis Media, Epistaxis & Vertigo
Key Takeaways Explain This Topic AI
Acute otitis media (AOM) is treated first-line with high-dose oral amoxicillin (80-90 mg/kg/day), whereas acute otitis externa (AOE) is managed with topical ciprofloxacin/dexamethasone drops.
Over 90% of epistaxis is anterior (Kiesselbach's plexus) and managed with compression, topical vasoconstrictors, or silver nitrate cautery.
Posterior epistaxis arises from the sphenopalatine artery, requires posterior balloon packing, and necessitates hospital admission for continuous cardiopulmonary monitoring.
Benign paroxysmal positional vertigo (BPPV) is diagnosed via the Dix-Hallpike maneuver and treated with the Epley maneuver, while vestibular suppressants are contraindicated.
Last updated: July 2026
Management of Middle and External Ear Infections
Ear pain (otalgia) and discharge (otorrhea) are frequent reasons for consultation. Accurately localizing the pathology to either the external canal or the middle ear space is the key to appropriate therapy.
Differentiating Otitis Media and Otitis Externa
- Clinical Feature Acute Otitis Media (AOM) Acute Otitis Externa (AOE)
- Anatomical Site Middle ear space (behind tympanic membrane) External auditory canal
- Pathogens S. pneumoniae , H. influenzae , M. catarrhalis Pseudomonas aeruginosa , S. aureus
- Risk Factors Eustachian tube dysfunction, viral URI, daycare Swimming, canal trauma (cotton swabs), eczema
- Symptoms Otalgia, fever, systemic illness, hearing loss Pruritus, severe otalgia, pain with chewing
Exam Findings Bulging, erythematous TM; loss of landmarks; decreased mobility on pneumatic otoscopy Tragal/auricular tenderness ; canal edema, erythema, and purulent debris; normal TM
- First-Line Rx Oral amoxicillin (high-dose) Topical ciprofloxacin/dexamethasone drops
- 1. Acute Otitis Media (AOM)
AOM is a bacterial infection of the middle ear fluid, most common in young children due to their shorter, more horizontal eustachian tubes.
Diagnosis: Requires acute onset of symptoms, middle ear effusion (documented by bulging TM or decreased mobility on pneumatic otoscopy ), and signs of middle ear inflammation (erythema or otalgia).
Management:
First-line: High-dose oral amoxicillin (80–90 mg/kg/day) divided into two doses.
Alternative (Penicillin Allergy): Cefdinir, cefuroxime, or azithromycin (in severe anaphylactic allergies).
Second-line / Treatment Failure (no improvement in 48-72 hours): Amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component) to cover beta-lactamase producing organisms.
Complications: Mastoiditis, meningitis, tympanic membrane perforation.
2. Acute Otitis Externa (AOE)
Commonly known as "swimmer's ear," AOE is an infection of the external auditory canal skin.
Diagnosis: Characterized by intense pain on manipulation of the auricle or tragus, canal swelling, and white/yellow discharge.
Management: Topical therapy is highly effective because it delivers high concentrations of medication directly to the site of infection.
First-line: Topical fluoroquinolone-corticosteroid drops (e.g., ciprofloxacin 0.3% / dexamethasone 0.1% ).
Alternative: Neomycin/polymyxin B/hydrocortisone drops. Note: Avoid neomycin-containing drops if the tympanic membrane is perforated or cannot be fully visualized, as aminoglycosides are ototoxic.
Severe Cases: If the canal is completely occluded, insert an ear wick to facilitate drug delivery.
Epistaxis Management: Stepwise Clinical Protocols
Epistaxis is classified by the anatomical source of bleeding. Proper localization guides the clinical response.
1. Anterior Epistaxis
Source: Over 90% of bleeds arise from Kiesselbach's plexus (an anastomosis of five arteries: sphenopalatine, anterior ethmoidal, greater palatine, septal branch of superior labial, and ophthalmic) on the anterior nasal septum.
Stepwise Management:
Direct Compression: Instruct the patient to blow out clots, then apply firm, continuous pressure to the cartilaginous nasal flares (pinching the nostrils) for 10–15 minutes. The patient must lean forward to prevent swallowing blood.
Topical Vasoconstrictors: If pressure fails, apply topical vasoconstrictors, such as oxymetazoline 0.05% spray or a cotton pledget soaked in epinephrine or cocaine solution.
Chemical Cautery: If a single bleeding vessel is clearly visible on the anterior septum, perform chemical cauterization using silver nitrate sticks . Apply the tip to the surrounding mucosa first, then directly to the bleeding point for 3–5 seconds. Caution: Never cauterize both sides of the nasal septum during the same visit, as this can cause ischemic necrosis leading to septal perforation.
Anterior Packing: If cauterization fails, insert an anterior nasal pack (e.g., Merocel nasal tampon or pneumatic balloon tamponade). Packs are typically left in place for 24–72 hours. Prophylactic oral antibiotics (e.g., cephalexin or amoxicillin-clavulanate) are often prescribed to reduce the risk of toxic shock syndrome, although evidence is mixed.
2. Posterior Epistaxis
Source: Arises from the sphenopalatine artery (Woodruff's plexus) in the posterior nasal cavity. More common in patients with pre-existing hypertension, atherosclerosis, coagulopathies, or those on anticoagulant therapy.
Clinical Presentation: Profuse bleeding from both nares, blood dripping rapidly down the posterior oropharynx even when anterior pressure is applied, and failure to control bleeding with anterior packing.
Management: Requires posterior nasal packing using a double-balloon catheter (e.g., Epistat) or a Foley catheter.
Critical Safety Directive: Posterior packing is highly painful and stimulates the nasopulmonary reflex, which can cause significant vagal stimulation, hypoventilation, hypoxemia, and bradycardia. All patients requiring posterior packing must be admitted to the hospital with continuous cardiac monitoring and pulse oximetry. Surgical ligation of the sphenopalatine artery or endovascular embolization is indicated if packing fails.
Differential Diagnosis of Peripheral Vertigo
Vertigo is the illusion of motion, typically spinning. Differentiating peripheral (inner ear) from central (brainstem/cerebellum) causes is a core clinical skill. Peripheral vertigo is characterized by horizontal-torsional, unidirectional nystagmus that is fatigable and suppressed by visual fixation.
1. Benign Paroxysmal Positional Vertigo (BPPV)
Pathophysiology: Calcium carbonate crystals (otoconia) dislodge from the utricle and migrate into the semicircular canals (usually the posterior canal).
Clinical Features: Recurrent, brief episodes of vertigo (lasting less than 60 seconds ) triggered by specific head movements (e.g., rolling over in bed, tilting the head back). No hearing loss or tinnitus.
Diagnosis: Dix-Hallpike maneuver , which elicits geotropic, torsional, upbeating nystagmus after a brief latency of a few seconds. The nystagmus is fatigable (decreases with repeated testing).
Management: Epley maneuver (canalith repositioning). Vestibular suppressants (e.g., meclizine) are ineffective and contraindicated, as they do not resolve the mechanical issue and can delay recovery.
2. Meniere's Disease (Endolymphatic Hydrops)
Pathophysiology: Increased volume and pressure of endolymph within the membranous labyrinth.
Clinical Features: Episodic vertigo lasting 20 minutes to several hours , accompanied by fluctuating low-frequency sensorineural hearing loss , low-pitched tinnitus , and a sensation of aural fullness in the affected ear.
Management:
Acute Attacks: Vestibular suppressants (meclizine, benzodiazepines) and antiemetics.
Maintenance: Lifestyle modifications including a strict low-sodium diet (<2,000 mg/day) , avoiding caffeine, alcohol, and nicotine. Oral diuretics (e.g., hydrochlorothiazide) or betahistine can be used to prevent attacks.
3. Vestibular Neuritis and Labyrinthitis
Pathophysiology: Post-viral inflammatory condition of the vestibular portion of cranial nerve VIII (vestibular neuritis) or both the vestibular and cochlear branches (labyrinthitis).
Clinical Features: Sudden, severe, continuous vertigo lasting days, accompanied by nausea, vomiting, and gait instability.
Vestibular Neuritis: Hearing is preserved.
Labyrinthitis: Associated with unilateral sensorineural hearing loss and/or tinnitus.
Exam Findings: Unidirectional, horizontal nystagmus beating away from the affected side, and an abnormal head impulse test (catch-up saccades when turning head toward the lesion).
Management:
Symptomatic: Short-term vestibular suppressants (e.g., meclizine 25mg or diazepam 2-5mg every 6 hours) for the first 48–72 hours only (prolonged use delays central vestibular compensation).
Anti-inflammatory: A 10-14 day course of oral prednisone initiated early improves functional recovery. Vestibular rehabilitation exercises are recommended for persistent imbalance.